What are the potential benefits of glucose-insulin-potassium infusion for patients with acute ST-segment elevation myocardial infarction?
The potential benefits of glucose-insulin-potassium infusion for patients with acute ST-segment elevation myocardial infarction were explored in the CREATE-ECLA randomized controlled trial (571). The results of the trial suggested that glucose-insulin-potassium infusion may reduce mortality in patients with acute ST-segment elevation myocardial infarction when compared to conventional glucose control (570). Additionally, other studies have found that glucose-insulin-potassium infusions may help improve outcomes in terms of length of stay in the hospital, and other measures of clinical outcomes (569, 570). 